临床与病理杂志2015，Vol.35Issue(12)：2095-2101,7.DOI:10.3978/j.issn.2095-6959.2015.12.017
利妥昔单抗治疗特发性炎性肌病的系统评价
Rituximab in the treatment of idiopathic inflammatory myopathies: a qualitative systematic review
摘要
关键词
利妥昔单抗/难治性/炎性肌病/皮肌炎/多发性肌炎/系统评价Key words
rituximab/refractory/idiopathic inflammatory myopathies (IIM)/dermatomyosits/polymyosits/systematic review引用本文复制引用
刘玉叶,陈秀敏,黄闰月,黄清春..利妥昔单抗治疗特发性炎性肌病的系统评价[J].临床与病理杂志,2015,35(12):2095-2101,7.基金项目
国家中医药管理局中医药标准化项目——皮肌炎[SATCM-2015-BZ(186)].This work was supported by the Standardization Program of The Traditional Chinese Medicine of the State Administration of traditional Chinese Medicine——Polymositis[SATCM-2015-BZ(186)],P.R.China. （186）
